Partnering

Biosilu Healthcare is actively pursuing collaborations with western biopharmaceutical companies seeking to make their innovative products available to patients in Asia / China.

We focus on development products, preferentially with a clinical-proof-of-concept in areas of high medical need in Asia. These areas include: infectious diseases, fertility, tumor indications and other rare diseases with high medical need among Asian patients.

The combination of a continued strong market demand with increasing efforts by Chinese regulatory authorities (CFDA) to accelerate the approval timelines also for foreign drugs while ensuring global standards in terms of quality and transparency of clinical development makes it more attractive for foreign innovation-based companies to enter the Chinese market early.

 

与我们合作

柏丝路正积极寻求对在华及亚洲发展感兴趣的生物制药界合作伙伴。

我们着重于研发中的产品,尤其是在亚洲有高度需求,并经临床概念验证的药物。产品领域包括:感染性疾病、辅助生育医疗、肿瘤以及其他罕见疾病。

在强劲的市场需求推动下,以及中国国家食品药品监督管理总局不断地努力加速对进口药物批准期限,并保障药品的质量和临床试验结果的透明度,更吸引国外创新制药公司尽早地进入中国市场